Texas A&M Science -- Fighting Fibrosis (VIDEO)
Caption
A decade after first identifying serum amyloid P (SAP) as a key protein in human blood that controls routine tissue-related processes from scarring to healing, Texas A&M biologists Richard Gomer and Darrell Pilling and the biotechnology company they co-founded, Promedior Inc., continue to make encouraging progress in the fight against fibrotic disease, a broad class of chronic conditions associated with an estimated 45 percent of US deaths per year. Learn more about their work at http://tx.ag/FightingFibrosis.
Credit
Texas A&M College of Science
Usage Restrictions
None
License
Licensed content